Delivery Order SPE2DB20D2104-SPE2DB23FS16F
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Forteo 600 mcg/2.4 ml pen injections. The fixed-price delivery order, valued at $2,749.98, does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $64,690.92, is for the delivery of Forteo 600 MCG/2.4 ML Pen Injection 2.4ML, a medication used to treat osteoporosis. This is a firm fixed-price delivery order contract with a completion date of September 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Forteo 560 mcg/2.24 ml pen injections, a medication used to treat osteoporosis. The contract has a ceiling value of $28,187.60 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition....
- This federal contract award, valued at $7,804.29, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Forteo 560 MCG/2.24 ML Pen Inj 2.24ML. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Forteo 560 mcg/2.24 ml pen injections. The award, valued at $17,159.56, is a firm fixed-price delivery order contract with a completion date of May 12, 2025. The contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,772.06 firm fixed-price delivery order is for the supply of 600 mcg/2.4 ml Forteo pen injections. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,165.94 delivery order is for the supply of Forteo, a 600 mcg/2.4 ml pen injection product. The award has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The federal contract award is a delivery order worth $2,749.98 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication. The delivery order has a firm fixed price and an ultimate completion date of June 23, 2025. The contract is not set aside and is awarded as an open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $5,242.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.29, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS16FDelivery Order
This federal contract award, valued at $2,658.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections, a medication used for the treatment of osteoporosis. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/11/23 |